Testosterone Administration To Men With Testosterone Deficiency Syndrome After External Beam Radiotherapy For Localized Prostate Cancer

Main Category: Prostate / Prostate Cancer
Also Included In: Urology / Nephrology;  Cancer / Oncology
Article Date: 05 Sep 2008 - 1:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:not yet rated


UroToday.com - Dr. Alvaro Morales and associates from the Centre for Applied Urological Research, reported on the first study on testosterone deficiency syndrome (TDS) in men treated with radiotherapy for prostate cancer. Five men with clinically localized CaP were prospectively studied. The mean Gleason sum was 7 and mean PSA level before radiotherapy was 12.8ng/ml. The mean PSA before testosterone replacement therapy (TRT) was 0.3ng/ml.

All five men had symptoms of TDS and two chose intramuscular injections of testosterone, one oral replacement and two used transdermal patches. Testosterone levels before TRT were 5.3 and at last visit were 17.6. The duration of follow-up was 14.6 months. One man had a transitory PSA increase, but none had levels of >1.5ng/ml.

All patients had marked responses in the symptoms of TDS, four with decreased hot flashes, decreased fatigue and improved libido, and two reported improved erectile function. One man discontinued therapy due to headaches. Four men had an improvement in sexual interest, but none recovered satisfactory erectile function with testosterone alone. A phosphodiesterase-5 inhibitor was successful in three men. The best overall symptom improvements were in hot flashes and fatigue. This report is hypothesis-generating for larger studies to address this issue.

Morales A, Black AM, Emerson LE
BJU Int. 2008 Jul 29. Epub ahead of print.
doi:10.1111/j.1464-410X.2008.07882.x

Reported by UroToday.com Contributing Editor Christopher P. Evans, MD, FACS

UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice.

To access the latest urology news releases from UroToday, go to: www.urotoday.com

Copyright © 2008 - UroToday

Article adapted by Medical News Today from original press release.
Visit our prostate / prostate cancer section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Urotoday. "Testosterone Administration To Men With Testosterone Deficiency Syndrome After External Beam Radiotherapy For Localized Prostate Cancer." Medical News Today. MediLexicon, Intl., 5 Sep. 2008. Web.
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/120399.php>

APA
Urotoday. (2008, September 5). "Testosterone Administration To Men With Testosterone Deficiency Syndrome After External Beam Radiotherapy For Localized Prostate Cancer." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/120399.php.

Please note: If no author information is provided, the source is cited instead.


Prostate / Prostate Cancer

Most Popular Articles



Follow Our Prostate News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Prostate / Prostate Cancer Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »